SCHEMBL475357

SCHEMBL475357

O=C(O)OCCCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL608988 0.97 TSHR (0.39)
SCHEMBL608730 0.92
SCHEMBL64893 0.86 TDP1 (0.44)
SCHEMBL8507336 0.83 TSHR (0.48)
SCHEMBL8505232 0.83 TSHR (0.48)
SCHEMBL8505895 0.83 TSHR (0.48)
SCHEMBL8508151 0.83 TSHR (0.48)
SCHEMBL1729891 0.83 TSHR (0.48)
SCHEMBL8505503 0.83 TSHR (0.48)
SCHEMBL284653 0.83 TSHR (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119366020-A Electrochemical device comprising a separator comprising PVDF and a high viscosity or high polarity electrolyte composition 阿科玛法国公司 2025-01-24 CN disclosed
WO-2024117205-A1 BICYCLIC PYRIDINE DERIVATIVE AND SALT THEREOF, AND HARMFUL ORGANISM CONTROL AGENT CHARACTERIZED BY CONTAINING SAID DERIVATIVE OR SALT THEREOF AS ACTIVE INGREDIENT 北興化学工業株式会社 2024-06-06 WO disclosed
CN-116640117-A Triazole LPAR1 antagonists and uses thereof 武汉人福创新药物研发中心有限公司 2023-08-25 CN disclosed
WO-2023109878-A1 TRIAZASPIRO LPAR1 ANTAGONIST AND USE THEREOF 武汉人福创新药物研发中心有限公司 2023-06-22 WO disclosed
EP-3488483-B1 LIQUID ELECTROLYTES FOR LITHIUM BATTERIES SOLVAY SPECIALTY POLYMERS IT (IT) 2023-02-22 EP disclosed
CN-110637389-B Lithium ion secondary battery 日本电气株式会社 2023-02-21 CN disclosed
CN-110720156-B Lithium ion secondary battery 日本电气株式会社 2023-01-06 CN disclosed
CN-115275324-A Secondary battery and method for using secondary battery 远景AESC日本有限公司 2022-11-01 CN disclosed
US-11469454-B2 Secondary battery and method for using secondary battery Envision AESC Janan Ltd. (JP) 2022-10-11 US disclosed
CN-108701812-B Negative electrode for lithium secondary battery and lithium secondary battery 日本电气株式会社 2022-09-23 CN disclosed
US-5541318-A Cephalosporins ROUSSEL UCLAF (FR) 1996-07-30 US disclosed
EP-0693496-A1 Novel cephalosporins having a substituted benzyloxyimino radical in position 7, process for their preparation and their use as medicaments ROUSSEL UCLAF (FR) 1996-01-24 EP disclosed
US-5378697-A BACTERICIDES ROUSSEL-UCLAF (FR) 1995-01-03 US disclosed
US-5373001-A Antibiotics ROUSSEL UCLAF (FR) 1994-12-13 US disclosed
EP-0315518-B1 Cephalosporins having in position 3 a substituted vinyl radical, their process for preparation, their application as medicaments, compositions containing them and intermediates ROUSSEL UCLAF (FR) 1994-02-16 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed
EP-0520880-A1 Cephalosporines having a 2-thia cephem ring, process for their preparation, pharmaceutical compositions containing them, their application as medicaments and intermediates ROUSSEL UCLAF (FR) 1992-12-30 EP disclosed
US-5075298-A Antibiotics ROUSSEL UCLAF (FR) 1991-12-24 US disclosed
EP-0462009-A1 Cephalosporins having in position 3 a propenyl radical substituted by a quaternary ammonium, their process for preparation, their use as medicaments, compositions containing them and intermediates ROUSSEL UCLAF (FR) 1991-12-18 EP disclosed
EP-0315518-A1 Cephalosporins having in position 3 a substituted vinyl radical, their process for preparation, their application as medicaments, compositions containing them and intermediates ROUSSEL-UCLAF (FR) 1989-05-10 EP disclosed